Publication | Open Access
FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction
54
Citations
34
References
2020
Year
The present study indicated that irisin or FNDC5 improved BM-MSC engraftment and paracrine effects in infarcted hearts, which might provide a potential therapeutic target for MI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1